- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05314647
Lutein Supplementation in Healthy Children
Effects of Lutein Supplementation on Cognition and Vision in Healthy Children With Screen Time Exposure: A Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Brenda Fonseca, MA
- Phone Number: 515-421-0680
- Email: brenda@brendafonseca.com
Study Locations
-
-
Iowa
-
Des Moines, Iowa, United States, 50307
- Kemin Industries
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age of 8 to 16 years
- guardian-reported general good health
- guardian-reported 4 hours or more of digital screen time daily
Exclusion Criteria:
- Currently using a supplement containing lutein or zeaxanthin
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Lutein
5 mg lutein gummy taken daily for 180 days
|
daily dose of 5 mg lutein
Other Names:
|
Placebo Comparator: Placebo
0 mg lutein gummy taken daily for 180 days
|
daily dose of 0 mg lutein
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Macular Pigment Optical Density - heterochromatic flicker photometry
Time Frame: 6 months
|
Level of macular carotenoids deposited in the eye measured using the psychophysical technique of heterochromatic flicker photometry (QuantifEye MPS-II Device).
Minimum score of 0, no maximum.
Average values range from 0.0 to 1.0.
Higher numbers represent greater macular pigment.
|
6 months
|
Macular Pigment Optical Density - haidinger's brushes
Time Frame: 6 months
|
Level of macular carotenoids deposited in the eye measured using haidinger's brushes (Azul Optics MP-Eye Device).
Minimum score of 0, maximum score of 10.
Higher values represent greater macular pigment.
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Digital Eye strain change from baseline
Time Frame: 6 months
|
Visual Fatigue Scale total score. Minimum score of 6, Maximum score of 24. Higher scores indicate higher levels of digital eye strain. Benedetto, S., Drai-Zerbib, V., Pedrotti, M., Tissier, G., & Baccino, T. (2013). E-readers and visual fatigue. PLoS One, 8(12) |
6 months
|
Sleep score change from baseline
Time Frame: 6 months
|
Total score on the Cleveland Adolescent Sleepiness Questionnaire. Minimum score of 16, Maximum score of 80. Higher scores indicate greater sleepiness. Spilsbury, J. C., et al. (2007). "The Cleveland adolescent sleepiness questionnaire: a new measure to assess excessive daytime sleepiness in adolescents." J Clin Sleep Med 3(6): 603-612. |
6 months
|
Verbal Fluency
Time Frame: 6 months
|
Letter and semantic fluency using letter and animal naming.
Total number of words names in a 60 second time frame.
Higher score indicates greater verbal fluency
|
6 months
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Patrick McNamara, PhD, Northcentral University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NorthcentralU
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cognitive Change
-
University Ramon LlullAinhoa Nieto Guisado; Mònica Solana-TramuntUnknownCognitive Change | Proprioception Change | Balance ChangeSpain
-
Applied Science & Performance InstituteRecruitingCognitive Change | Mood Change | Mental ProcessesUnited States
-
National Council of Scientific and Technical Research...CompletedSleep | Cognitive Change | Mood Change | CreativityArgentina
-
Wake Forest UniversityNot yet recruiting
-
Biruni UniversityCompletedCognitive ChangeTurkey
-
University of MemphisCalerie LLCCompletedCognitive ChangeUnited States
-
Oregon Health and Science UniversityCompleted
-
University of MiamiUnited States Department of DefenseCompleted
-
Northumbria UniversityPerfetti van Melle SPACompletedCognitive ChangeUnited Kingdom
-
Universidad de GranadaCompleted
Clinical Trials on lutein
-
Peking UniversityUnknownAge-related Macular DegenerationChina
-
Peking UniversityCompletedAge-related Macular DegenerationChina
-
National Eye Institute (NEI)Completed
-
Chrysantis, Inc.Kowa Company, Ltd.; IMAGE TECHNOLOGIES INC.CompletedCognition Disorders | Age Related Macular DegenerationUnited States
-
University of GeorgiaDSM Nutritional Products, Inc.Completed
-
Wageningen UniversityCompleted
-
Johns Hopkins UniversityClark Charitable Foundation Inc.CompletedOcular Albinism (OA) | Oculocutaneous Albinism (OCA)United States
-
University of CopenhagenRigshospitalet, Denmark; Glostrup University Hospital, Copenhagen; Agroscope... and other collaboratorsTerminatedHealthy | Ileostomy; Functional DisturbanceDenmark
-
Federal University of São PauloCompletedProliferative Diabetic Retinopathy | Epiretinal Membrane | Macular HoleBrazil
-
DSM Nutritional Products, Inc.Abbott NutritionCompleted